Form D · Other Health Care
Xenocor, Inc.
Salt Lake City, UT · CIK 0001967070
Offering snapshot reported Mar 21, 2023 · SEC filing
- Reported sold
- $4.96M Offering amount: $10M
- Investors reported
- 89 Form D · investor count
- Minimum accepted
- $12.5K Reported outside-investor minimum
- First sale
- Aug 5, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2023 | Initial | $4,957,167 | No comparison | 89 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476513
PER THE CAPITALIZATION TABLE THE TOTAL REMAINING TO BE SOLD IS $5,042,832,.30, HOWEVER, IT WILL NOT LET ME INPUT THE CENTS ON HERE.
Source: Form D, filed Mar 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Baran | Director |
| Charles Decoster Iv | Director, Executive |
| Shawn Fojtik | Director |
| Mark Foster | Director |
| Jim Hogan | Director |
| Dinesh Patel | Director |
| Antony Watson | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
630 Komas Dr. #200
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108